Don't wait lose weight with NutriSystem pasta
Showing posts with label eye. Show all posts
Showing posts with label eye. Show all posts

Tuesday, April 12, 2011

Allergy Sufferers Contend With Longer Allergy Season

/PRNewswire/ -- The 2011 allergy season is expected to be 27 days longer in northernmost parts of North America,(1) adding almost a month of suffering to the typical pollen allergy season of February/March-October,(2) according to a study published by the Proceedings of the National Academy of Sciences.

The longer allergy season could be particularly rough on eye allergy sufferers, notes a leading expert. "Ocular (eye) allergies affect one in every five individuals and it is estimated that 50 percent of individuals with seasonal and indoor allergies also experience some degree of ocular allergy,"(3,4) says Paul Karpecki, O.D., F.A.A.O., Clinical Director, Koffler Vision Group, Lexington, Kentucky. Dr. Karpecki offers the following advice to allergy sufferers:

* Find out what causes your allergy and try to avoid the trigger. "If pollen is what bothers you, try to stay indoors and minimize the amount of time you are in the wind, which blows allergens around."
* Be cautious with allergy pills that claim to ease allergy symptoms. "Quite frequently, allergy medication can dry the eyes out. If you must take an allergy pill, try to take it at night so the drying effect is not as dramatic. Talk to your doctor about what medication(s) are best for you."
* Allergy season is particularly challenging for some contact lens wearers because allergens and other irritants can build up on contacts over time, leading to discomfort and symptoms such as itching, tearing and redness. "Daily disposable lenses like 1-DAY ACUVUE® MOIST® Brand Contact Lenses are a healthy and more comfortable option for any lens wearer. Putting a clean, fresh lens into the eye each day minimizes the potential for the buildup of irritants that occur with repeated use of the same pair of lenses."
* Use preservative-free artificial tears. "People who suffer from eye allergy symptoms may also find that the preservatives in artificial tears also cause discomfort."
* Consider allergy drops, which are prescribed by a doctor. "I tell my patients to put the drops in each eye in the morning before inserting contact lenses and then put a few drops in at night after they remove their lenses."
* Take more frequent showers to wash away allergens and at night, turn off ceiling fans, as allergens and dust are easily picked up by a fan.
* Take a cool washcloth and place it over the eyes to ease swelling and discomfort. "Relax for a bit with the washcloth over the eyes to relieve symptoms."


To help allergy sufferers better understand and manage their condition, the Asthma and Allergy Foundation of America (AAFA) offers a free educational brochure titled "Eye Health and Allergies." The brochure, which also includes smart allergy season strategies for contact lens wearers, can be viewed or downloaded at www.aafa.org/eyeallergies. The brochure, along with a free trial-pair certificate* for 1-DAY ACUVUE® MOIST® Brand is also available at www.acuvue.com/seasons.

Important information for contact lens wearers: ACUVUE® Brand Contact Lenses are available by prescription only for vision correction. An eye care professional will determine whether contact lenses are right for you. Although rare, serious eye problems can develop while wearing contact lenses. To help avoid these problems, follow the wear and replacement schedule and the lens care instructions provided by your eye doctor. Do not wear contact lenses if you have an eye infection, or experience eye discomfort, excessive tearing, vision changes, redness or other eye problems. If one of these conditions occurs, contact your eye doctor immediately. For more information on proper wear, care and safety, talk to your eye care professional and ask for a Patient Instruction Guide, call 1-800-843-2020 or visit Acuvue.com.

Clinical research has shown when worn on a daily disposable basis, 1 - DAY ACUVUE® Brand Contact Lenses and other daily disposable etafilcon A contact lenses such as 1 - DAY ACUVUE® MOIST® Brand Contact Lenses may provide improved comfort for many patients suffering from mild discomfort and/or itching associated with allergies during contact lens wear compared to lenses replaced at intervals of greater than 2 weeks.

*Professional exam and fitting fees not included. Valid only while supplies last.

1) Ziska, Lewis et al. Recent Warming By Latitude Associated with Increased Length of Ragweed Pollen Season in Central North America. Proceedings of the National Academy of Sciences. 8 March 2011.

2) Tips to Remember: Outdoor Allergens. American Academy of Allergy Asthma & Immunology Web site. http://www.aaaai.org/patients/publicedmat/tips/outdoorallergens.stm. Accessed March 16, 2011.

3) Katelaris CH, Bielory L. Evidence-based study design in ocular allergy trials. Curr Opin Allergy Clin Immunol. 2008;8(5):484-488.

4) Bassett C. Ocular Allergies. Asthma & Allergy Advocate. Summer 2007. American Academy of Allergy Asthma & Immunology Web site. www.aaaai.org/patients/advocate/. Accessed November 3, 2008.

ACUVUE® and 1 -DAY ACUVUE® MOIST® are trademarks of Johnson & Johnson Vision Care, Inc.

-----
Community News You Can Use
Click to read MORE news:
www.GeorgiaFrontPage.com
Twitter: @gafrontpage & @TheGATable @HookedonHistory
www.ArtsAcrossGeorgia.com
Twitter: @artsacrossga, @softnblue, @RimbomboAAG @FayetteFP

Tuesday, January 13, 2009

From Outer Space To The Eye Clinic

(NAPSI)-A device developed for the space program is now also valuable for eye care patients as the first noninvasive early detection device for cataracts, the leading cause of vision loss worldwide.

Researchers from the National Eye Institute (NEI), part of the National Institutes of Health, and the National Aeronautics and Space Administration (NASA) collaborated to develop a simple, safe eye test for measuring a protein related to cataract formation. If subtle protein changes can be detected before a cataract develops, people may be able to reduce their cataract risk by making simple lifestyle changes, such as decreasing sun exposure, quitting smoking, stopping certain medications and controlling diabetes.

"By the time the eye's lens appears cloudy from a cataract, it is too late to reverse or medically treat this process," said Manuel B. Datiles III, M.D., NEI medical officer and lead author of the study. "This technology can detect the earliest damage to lens proteins, triggering an early warning for cataract formation and blindness."

The new device is based on a laser light technique initially developed to analyze the growth of protein crystals in a zero-gravity space environment. NASA's Rafat R. Ansari, Ph.D., senior scientist at the John H. Glenn Research Center and co-author of the study, brought the technology's possible clinical applications to the attention of NEI vision researchers when he learned that his father's cataracts were caused by changes in lens proteins.

Several proteins are involved in cataract formation. One known as alpha-crystallin binds to others, keeping them from forming a cataract. However, humans are born with a fixed amount of alpha-crystallin, so if the supply becomes depleted due to radiation exposure, smoking, diabetes or other causes, a cataract can result.

The technique may also prove useful in early detection of other diseases such as Alzheimer's and Parkinson's in which an abnormal protein may be found, added Dr. Ansari. "By understanding the role of protein changes in cataract formation, we can use the lens not just to look at eye disease but also as a window into the whole body."

"This research is a prime example of two government agencies sharing scientific information for the benefit of the American people," said NEI director Paul A. Sieving, M.D., Ph.D.

The DLS technique will now assist vision scientists in looking at long-term lens changes due to aging, smoking, diabetes, LASIK surgery, eye drops for treating glaucoma and surgical removal of the vitreous gel within the eye, a procedure known to cause cataracts within six months to one year. It may also help in the early diagnosis of Alzheimer's disease, in which an abnormal protein may be found in the lens.

For more information, visit www.nei.nih.gov and www.grc.nasa.gov.

-----
www.fayettefrontpage.com
Fayette Front Page
www.georgiafrontpage.com
Georgia Front Page

Tuesday, July 15, 2008

Seniors Fight Age-Related Eye Disease With Breakthrough Treatment

(NAPSI)-When Bonnie Conway began to experience vision loss due to an eye disease known as wet age-related macular degeneration, or wet AMD, she worried that she might have to leave her job. As Borough Manager of her local community, Conway relies heavily on her sight to complete her bookkeeping, filing and letter writing duties.

More than 15 million American seniors live with some form of AMD, a leading cause of blindness in people over 60. There are two forms of AMD, dry and wet. While all cases begin as the dry form, it is the wet form that accounts for about 90 percent of all AMD-related blindness.

Wet AMD can result in sudden and severe loss of a person’s central vision, and can worsen rapidly without treatment. Like many of the 1.7 million people with the advanced form of the disease, Conway had difficulty reading and the faces of her friends and loved ones became blurry.

“I was a big reader. The most frustrating thing for me was losing the ability to read without a magnifying glass,” said Conway. “I started to accept that my wet AMD would eventually get so bad that I’d have to give up my job.”

But in August of 2006, Conway’s eye doctor, a retina specialist, began treating her with monthly injections of Lucentis® (ranibizumab injection), which is approved by the U.S. Food and Drug Administration for the treatment of wet AMD. Since starting treatment, Conway’s vision has improved from 20/80 to 20/40 on the eye chart.

“Bonnie was one of the first patients in our practice to receive Lucentis, and because she’s continued to come for treatment every month, her vision has improved and she’s been able to continue her normal activities,” said Dr. Miguel Busquets of Associates in Ophthalmology.

In clinical studies of Lucentis, nearly all patients (90 percent) treated once a month maintained their vision for up to two years. About 40 percent of patients’ vision actually improved by three lines or more on the study eye chart at two years, though a few patients have experienced some vision loss.

Because AMD advances so quickly, and can cause sudden and irreversible loss of vision, early diagnosis and treatment are critical. The National Eye Institute recommends that people aged 60 or older schedule eye exams every two years, and anyone who notices changes in vision should receive an eye exam right away.

Lucentis is a prescription medication given by injection into the eye. Lucentis has been associated with detached retina and serious eye infection and should not be used in patients who have an infection in or around the eye. Increases in eye pressure have been seen within one hour of an injection. Although uncommon, conditions associated with eye- and non-eye-related blood clots (arterial thromboembolic events) may occur. Serious side effects included inflammation inside the eye and, rarely, effects related to the injection procedure such as cataract. The most common non-eye-related side effects were nose and throat infection, headache, and respiratory and urinary tract infections. The most common eye-related side effects were the feeling that something is in your eye, and increased tears.

If your eye becomes red, sensitive to light, painful or has a change in vision, you should seek immediate care from your eye doctor.